Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Metadata
Title
Newborn screening in Latin America at the beginning of the 21st century
Author
G. J. C. Borrajo
Publication date
01-08-2007
Published in
Journal of Inherited Metabolic Disease / Issue 4/2007
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-007-0669-9

Other articles of this Issue 4/2007

Journal of Inherited Metabolic Disease 4/2007 Go to the issue

Newborn Screening

Structures for clinical follow-up: Newborn screening

Short Report

Quantification of N-acetylaspartic acid in urine by LC-MS/MS for the diagnosis of Canavan disease

Neonatal Screening

Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: A four-year report

Newborn Screening

Congenital adrenal hyperplasia: Diagnostic advances

Newborn Screening – Short Report

Direct comparison of enzyme measurements from dried blood and leukocytes from male and female Fabry disease patients

Newborn Screening

Implementation of extended neonatal screening and a metabolic unit in the State of Qatar: Developing and optimizing strategies in cooperation with the Neonatal Screening Center in Heidelberg

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits